NVS vs. MKA.L
NVS (Novartis AG) and MKA.L (Mkango Resources Ltd) are both stocks. NVS operates in Drug Manufacturers - General (Healthcare), while MKA.L operates in Other Industrial Metals & Mining (Basic Materials). Over the past 5 years, NVS returned 13.87%/yr vs 5.07%/yr for MKA.L. At a 0.07 correlation, their price movements are largely independent.
Performance
NVS vs. MKA.L - Performance Comparison
Loading charts...
Different Trading Currencies
NVS is traded in USD, while MKA.L is traded in GBp. To make them comparable, the MKA.L values have been converted to USD using the latest available exchange rates.
Returns By Period
In the year-to-date period, NVS achieves a 9.43% return, which is significantly higher than MKA.L's -10.47% return.
NVS
- 1D
- -1.84%
- 1M
- 0.27%
- YTD
- 9.43%
- 6M
- 15.91%
- 1Y
- 27.84%
- 3Y*
- 17.18%
- 5Y*
- 13.87%
- 10Y*
- 10.33%
MKA.L
- 1D
- 2.49%
- 1M
- -7.63%
- YTD
- -10.47%
- 6M
- -15.90%
- 1Y
- 147.26%
- 3Y*
- 60.60%
- 5Y*
- 5.07%
- 10Y*
- —
NVS vs. MKA.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVS Novartis AG | 9.43% | 46.95% | 0.02% | 16.14% | 8.06% | -3.65% | 3.34% | 13.92% | 5.95% | 19.42% |
MKA.L Mkango Resources Ltd | -10.47% | 529.04% | -32.02% | -1.17% | -64.71% | 75.54% | 109.72% | 4.01% | 11.91% | 144.31% |
Correlation
The correlation between NVS and MKA.L is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2016 | 0.07 |
Fundamentals
NVS:
$280.54B
MKA.L:
£146.26M
NVS:
$6.99
MKA.L:
-£0.04
NVS:
5.06
MKA.L:
2.72K
NVS:
$56.05B
MKA.L:
£50.78K
NVS:
$42.19B
MKA.L:
-£544.15K
NVS:
$22.40B
MKA.L:
-£17.87M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVS vs. MKA.L — Risk / Return Rank
NVS
MKA.L
NVS vs. MKA.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novartis AG (NVS) and Mkango Resources Ltd (MKA.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NVS | MKA.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.18 | ||
| Sortino ratioReturn per unit of downside risk | -0.63 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.28 | -0.05 |
| Calmar ratioReturn relative to maximum drawdown | 2.21 | 2.84 | -0.63 |
| Martin ratioReturn relative to average drawdown | 5.43 | 5.91 | -0.48 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NVS | MKA.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.36 | 1.54 | -0.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.74 | 0.07 | +0.68 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.53 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.42 | 0.27 | +0.15 |
Drawdowns
NVS vs. MKA.L - Drawdown Comparison
The maximum NVS drawdown since its inception was -42.10%, smaller than the maximum MKA.L drawdown of -89.22%. Use the drawdown chart below to compare losses from any high point for NVS and MKA.L.
Loading charts...
Drawdown Indicators
| NVS | MKA.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -42.10% | -89.22% | +47.12% |
Max Drawdown (1Y)Largest decline over 1 year | -12.65% | -51.55% | +38.90% |
Max Drawdown (3Y)Largest decline over 3 years | -19.95% | -66.46% | +46.51% |
Max Drawdown (5Y)Largest decline over 5 years | -20.42% | -89.22% | +68.80% |
Max Drawdown (10Y)Largest decline over 10 years | -26.03% | — | — |
Current DrawdownCurrent decline from peak | -10.52% | -39.03% | +28.51% |
Average DrawdownAverage peak-to-trough decline | -10.93% | -45.46% | +34.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 24.81% | -19.67% |
Volatility
NVS vs. MKA.L - Volatility Comparison
The current volatility for Novartis AG (NVS) is 6.16%, while Mkango Resources Ltd (MKA.L) has a volatility of 22.35%. This indicates that NVS experiences smaller price fluctuations and is considered to be less risky than MKA.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVS | MKA.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.16% | 22.35% | -16.19% |
Volatility (6M)Calculated over the trailing 6-month period | 14.45% | 48.60% | -34.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.63% | 95.35% | -74.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.85% | 77.87% | -59.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.62% | 96.62% | -77.00% |
Dividends
NVS vs. MKA.L - Dividend Comparison
NVS's dividend yield for the trailing twelve months is around 3.26%, while MKA.L has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MKA.L Mkango Resources Ltd | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVS Novartis AG | 3.26% | 2.90% | 3.84% | 3.44% | 3.70% | 3.86% | 3.22% | 3.03% | 3.47% | 3.24% | 3.73% | 3.10% |
Financials
NVS vs. MKA.L - Financials Comparison
This section allows you to compare key financial metrics between Novartis AG and Mkango Resources Ltd. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NVS and MKA.L have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NVS and MKA.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer